Share on

North America Home Insemination Products Market Research Report – Segmented By Procedure (Intrauterine Insemination, Intracervical Insemination, Intratubal Insemination), Product Type (Insemination Kits, Home Conception Devices, Accessories), End User (Hospital & Clinics, Fertility Centres, Home Care Settings, Others), and Country (U.S, Canada & Rest of North America) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2024 to 2029)

Published: March, 2023
ID: 11146
Pages: 145
Formats: report pdf report excel report power bi report ppt

North America Home Insemination Products Market Size (2024 to 2029)

The North America home insemination products market is expected to grow at a whopping CAGR of 7.61% from 2024 to 2029 and be worth USD 1.98 billion by 2029 from USD 1.37 billion in 2024.

The North America market is estimated to grow due to key driving factors like growing support from government authorities in approving the latest technological developments and rising infertility problems among men and women associated with lifestyle changes. 

Infertility is common in developed countries. In the United States, out of 100 couples, about 12 to 13 of the couples have trouble becoming pregnant. About 10 out of 100 (6.1 million) women in the U.S. aged 26–40 years have difficulty becoming pregnant or staying pregnant, based on the Centers for Disease Control and Prevention. Hence, women are opting more for home insemination, which provides privacy and ease. As a result, key medical organizations are keen on investing more in Home Insemination products, and this is expected to drive the North American home insemination market growth during the forecast period (2023-2028).

Stringent government laws and rising concern about safety are set to hamper the expansion of the North American home Insemination market. There is high possibility of a woman giving birth to twins or triplets hampering the expansion of the home Insemination Market over the forecast period. The market is predicted to experience slow growth during the conjecture period due to expensive procedures of reproductive techniques.

Impact of COVID-19 on the North America home insemination market:

The recent outbreak of the Coronavirus has turned the spotlight on the healthcare industry and subsequently affected the Home Insemination market. Severe shortages of critical medical supplies and a rapid increase in the number of COVID-19 cases have resulted in a revolution and thus affected the evolution in the healthcare ecosystems. Following government measures, particularly stay-at-home orders, and social distancing norms, doctors are postponed preventing the spread of Coronavirus. Further, supply chain disruptions and movement restrictions have created a logistical nightmare for market players, resulting in severe product shortages in the global marketplace.

This research report on the North America home insemination products market has been segmented and sub-segmented into the following categories.

North America Home Insemination Products Market - By Procedure:

  • Intracervical insemination
  • Intrauterine insemination
  • Intratubal insemination

The intrauterine insemination sub-segment is to lead the dominant shares of the market. Rising investments in the improvement of healthcare are leveling up the demand of the market.

North America Home Insemination Products Market – By Product Type:

  • Home conception devices
  • Insemination kits
  • Accessories.

Among these, the insemination kits segment is estimated to be the fastest-growing segment in terms of value because of the growing geriatric population and is predicted to generate higher revenue during the foreseen period

North America Home Insemination Products Market – By End-user:

  • Fertility centers
  • Hospitals
  • Clinics
  • Home care settings
  • Others

The fertility centers segment is estimated to carry the largest share of the regional market during the forecast period. Focus on the development of new innovative kits in favor of the end-user is likely to flourish the growth rate of this segment. 

North America Home Insemination Products Market – By Region:

  • USA
  • Canada

The demand for home insemination kits in the United States is gearing up for the past few years owing to increasing disposable income. North America dominated the home Insemination Market in 2020 with a share of over 41.02%. This is because of the growing demand for Home Insemination by single mothers & lesbian couples and the increasing prevalence of infertility among adults. Technological advancements, favorable rules and regulations, and increasing health sector and private sector investments are factors expanding the growth rate of the home Insemination Market in North America.

KEY MARKET PLAYERS:

The major key players in the North America Home Insemination Products Market are Rocket Medical plc, INVO Bioscience, Medgyn Products, Inc, Kitazato Corporation,  Fujifilm Irvine Scientific, Genea Limited, Rinovum Women's Health, LLC, Vitrolife, Hi-Tech Solutions.

RECENT HAPPENINGS IN THE MARKET:

  • In August 2019, Hamilton Throne acquired Planer Ltd to develop research. This acquisition enhances the product offerings in cryopreservation, incubation, and lab monitoring solutions and focuses on decreasing cost, increasing productivity, and improving results.
  • In September 2020, MedGyn acquired Thomas Medical. This will allow MedGyn to concentrate on domestic manufacturing and distribution globally while providing customers access to Thomas Medical’s product portfolio. 

Please wait. . . . Your request is being processed

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample